ASX Share rice
Wed 12 Aug 2020 - 07:04:pm (Sydney)

CGS Share Price

COGSTATE LTDCGSHealth Care Equipment & Services

CGS Company Information

Name:

Cogstate Limited

Sector:

Healthcare

Industry:

Health Information Services

GIC Industry:

Health Care Technology

GIC Sub Industry:

Health Care Technology

Address:

255 Bourke Street Melbourne VIC Australia 3000

Phone:

61 3 9664 1300

Full Time Employees:

158

CEO, MD & Exec. Director:

Mr. Bradley O'Connor C.A., B.Bus, CA

Chief Scientific Officer:

Dr. Paul Maruff BBSc (Hons), Ph.D.

Financial Controller & Company Sec.:

Mr. Keith Hawkins

Interim Chief Technology Officer:

Mr. Brendan Owen

Gen. Counsel & Company Sec.:

Mr. John Glueck

Company Overview:

Cogstate Limited, a cognitive science company, provides computerized cognitive tests for clinical trials, academic research, healthcare, and brain health applications in Australia and internationally. The company's services include scientific consultancy, project management, data management, statistical analysis, and reporting. It operates in three segments: Clinical Trials, Academic Research, and Healthcare. The Clinical Trials segment provides technology and associated services that are used to quantify the effect of diseases and drugs, and devices or other interventions on human subjects participating in clinical trials primarily conducted by pharmaceutical and biotechnology companies. The Academic Research segment offers technology and associated services to support international research studies and academic collaborations across various indications, including Alzheimer's disease, HIV, multiple sclerosis, pediatric and adult oncology, Parkinson's disease, epilepsy, and schizophrenia. As of June 30, 2019, it had participated in approximately 1,400 academic research studies in approximately 150 indications. The Healthcare segment provides Cognigram, a system for regular and standardized testing to assist in the early detection of cognitive decline. The company serves biopharmaceutical companies, sporting organizations, military, physicians and patients, academic institutions, and public-private partnerships. Cogstate Limited has a license agreement with Eisai Co., Ltd. Cogstate Limited was founded in 1999 and is headquartered in Melbourne, Australia.

CGS Share Price Information

Shares Issued:

170.14M

Market Capitalisation:

$110.59M

Revenue (TTM):

$20.41M

Revenue Per Share (TTM):

$0.15

Earnings per Share:

$-0.021

Profit Margin:

-0.1268

Operating Margin (TTM):

$-0.17

Return On Assets (TTM):

$-0.09

Return On Equity (TTM):

$-0.20

Quarterly Revenue Growth (YOY):

-0.128

Gross Profit(TTM):

$10.02M

Diluted Earnings Per Share (TTM):

$-0.019

CGS CashFlow Statement

CashFlow Date:

2019-06-30

Investments:

$-3,389,903.04

Change To Liabilities:

$53.34K

Total Cashflow From Investing Activities:

$-2,377,339

Net Income:

$-3,558,772.28

Total Cash From Operating Activities:

$372.37K

Depreciation:

$495.44K

Other Cashflow From Investing Activities:

$62.70K

Change To Account Receivables:

$2.06M

Capital Expenditures:

$3.48M

CGS Income Statement

Income Date:

2019-06-30

Income Before Tax:

$-5,490,829.89

Net Income:

$-3,558,772.28

Gross Profit:

$14.49M

Operating Income:

$-8,342,877.51

Interest Expense:

$119.78K

Income Tax Expense:

$-1,354,952

Total Revenue:

$31.13M

Total Operating Expenses:

$22.83M

Cost Of Revenue:

$16.65M

CGS Balance Sheet

Balance Sheet Date:

2019-06-30

Intangible Assets:

$7.05M

Total Liabilities:

$13.01M

Total Stockholder Equity:

$14.42M

Other Current Liabilities:

$2.21M

Total Assets:

$27.43M

Common Stock:

$25.34M

Other Current Assets:

$1.77M

Retained Earnings:

$-14,180,717

Other Liabilities:

$340.44K

Other Assets:

$3.69M

Cash:

$4.59M

Total Current Liabilities:

$12.53M

Short-Term Debt:

$720.06K

Property - Plant & Equipment:

$1.34M

Net Tangible Assets:

$5.17M

Total Current Assets:

$13.21M

Net Receivables:

$6.10M

Short-Term Investments:

$14.22M

Accounts Payable:

$892.48K

Non Currrent Assets (Other):

$14.22M

Short-Term Investments:

$14.22

Non Current Liabilities Total:

$485.44K

CGS Share Price History

CGS News

11 Aug, 2020
It is not uncommon to see companies perform well in the years after insiders buy shares. The flip side of that is that...
We often see insiders buying up shares in companies that perform well over the long term. On the other hand, we'd be...
12 Nov, 2019
It is doubtless a positive to see that the Cogstate Limited (ASX:CGS) share price has gained some 64% in the last...